Search

Displaying results 4021 - 4030 of 4300 in total
  1. Drug

    Annamycin

    go.drugbank.com/drugs/DB06420
    Investigational

  2. Drug

    INM005

    go.drugbank.com/drugs/DB16499
    Investigational

    INM005 was under investigation in clinical trials for the treatment of COVID-19. It was studied for pharmacokinetics, efficacy, and safety in a completed trial (NCT04494984). Additionally, a retrospective cohort study investigated the ef...

  3. Drug

    Ramoplanin

    go.drugbank.com/drugs/DB04952
    Experimental

    Ramoplanin is a novel glycolipodepsipeptide antibiotic under development for the treatment of CDAD.

  4. Drug

    EGEN-001

    go.drugbank.com/drugs/DB05953
    Investigational

    EGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity.

  5. Drug

    Tezacitabine

    go.drugbank.com/drugs/DB06433
    Investigational

    A synthetic purine nucleoside analogue with potential antineoplastic activity.

  6. Drug

    ZYCOV-D

    go.drugbank.com/drugs/DB15892
    Experimental

    The ZYCOV-D vaccine candidate was developed by Cadila Healthcare Ltd. based in India[A219758].

  7. Drug

    Etofenamate

    go.drugbank.com/drugs/DB08984
    Investigational

    Etofenamate is used to treat muscle and joint paint. It is a non-steroidal anti-inflammatory drug (NSAID).

  8. Drug

    L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal

    go.drugbank.com/drugs/DB06124
    Experimental

    C-101, also called Myodur, is developed for the treatment of Duchenne’s muscular dystrophy (DMD) which is a morbid genetic disease that can lead to death in late adolescence due to accelerated skeletal muscle breakdown. C-101 includes a ...

  9. Drug

    AVR118

    go.drugbank.com/drugs/DB04979
    Investigational

    infection and chemotherapeutic drugs employed in the treatment of cancers); for its ability to stimulate the immune system to attack tumor cells (especially those cancer cells that have been damaged by

  10. Drug

    BBV152

    go.drugbank.com/drugs/DB15847
    Investigational

    BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR).